Loading clinical trials...
Loading clinical trials...
A National, Multi-center Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period
Conditions
Interventions
Teriflunomide
Locations
5
France
CHU de Besançon
Besançon, France
CHU de Lille
Lille, France
CHU de Montpellier
Montpellier, France
CHU de Nice
Nice, France
CHU de Strasbourg
Strasbourg, France
Start Date
December 18, 2015
Primary Completion Date
August 31, 2020
Completion Date
August 31, 2021
Last Updated
March 22, 2023
NCT07225504
NCT06276634
NCT06809192
NCT05359653
NCT07426991
NCT07376772
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions